ACXP - Acurx Pharmaceuticals regains compliance with Nasdaq's listing rules
2025-09-03 07:42:51 ET
More on Acurx Pharmaceuticals
- Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript
- Acurx signals ongoing cost controls and new trial funding avenues while advancing ibezapolstat clinical program
- Acurx Pharmaceuticals files $50M mixed shelf offering
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
- Historical earnings data for Acurx Pharmaceuticals